LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Verena Gounden Diala El-Maouche Brian R Stolze Ranganath Muniyappa Steven J Soldin

Ther Drug Monit

*Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland †National Institutes of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland ‡National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland §Department of Medicine, Georgetown University, Washington, District of Columbia.

Published: December 2014

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225186	PMC
http://dx.doi.org/10.1097/FTD.0000000000000086	DOI Listing

Publication Analysis

Top Keywords

lc-ms/ms detection

detection increased

increased androstenedione

androstenedione levels

levels patients

patients receiving

receiving danazol

danazol therapy

lc-ms/ms

increased

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!